Article Details
Retrieved on: 2024-11-13 11:38:25
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Insilico Medicine's success in using generative AI to develop ISM001-055, a drug for idiopathic pulmonary fibrosis, highlighting positive Phase IIa trial results. The tags connect key elements like clinical trials and Alex Zhavoronkov.
Article found on: businessnewsthisweek.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here